MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
381.31%
Quick Ratio
381.31%
Cash Ratio
236.23%
Debt to Asset Ratio
26.04%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Right of use asset, net
    • Less accumulated depreciation
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Warrant liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
44,185
37,371
29,198
42,695
Prepaid expenses and other current assets
9,895
8,959
7,692
7,592
Marketable securities
17,240
17,215
12,071
-
Total current assets
71,320
63,545
48,961
50,287
Right of use asset, net
668
813
108
249
Subtotal
106
106
138
138
Less accumulated depreciation
65
58
72
63
Property and equipment, net
41
48
66
75
Total assets
72,029
64,406
49,135
50,611
Accounts payable
2,234
1,140
383
957
Accrued liabilities
2,136
3,052
1,523
2,762
Warrant liability
13,718
21,695
16,915
9,147
Operating lease liability - current
616
598
117
265
Total current liabilities
18,704
26,485
18,938
13,131
Operating lease liability long term
55
217
-
0
Total liabilities
18,759
26,702
18,938
13,131
Common stock, 0.001 par value per share 400,000,000 shares authorized at december 31, 2025, and june 30, 2026 22,114,245 and 27,855,257 shares issued and outstanding at december 31, 2025, and june 30, 2026, respectively
28
25
22
21
Accumulated other comprehensive loss
-23
6
-1
-
Additional paid-in capital
195,635
178,321
158,001
150,617
Accumulated deficit
-142,370
-140,648
-127,825
-113,158
Preferred stock, value-Series A2Preferred Stock
-
-
-
0
Preferred stock, value-Series B2Preferred Stock
-
-
-
0
Preferred stock, value
-
-
-
0
Total stockholders equity
53,270
37,704
30,197
37,480
Total liabilities and stockholders equity
72,029
64,406
49,135
50,611
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$44,185K (97.90%↑ Y/Y)Marketable securities$17,240K Prepaid expenses andother current assets$9,895K (37.45%↑ Y/Y)Subtotal$106K (-22.06%↓ Y/Y)Total current assets$71,320K (141.55%↑ Y/Y)Right of use asset, net$668K (73.06%↑ Y/Y)Property and equipment,net$41K (-50.60%↓ Y/Y)Less accumulateddepreciation$65K (22.64%↑ Y/Y)Total assets$72,029K (140.14%↑ Y/Y)Total liabilities andstockholders equity$72,029K (140.14%↑ Y/Y)Total stockholdersequity$53,270K (224.24%↑ Y/Y)Total liabilities$18,759K (38.28%↑ Y/Y)Accumulated deficit-$142,370K (-32.87%↓ Y/Y)Accumulated othercomprehensive loss-$23K Additional paid-in capital$195,635K (58.47%↑ Y/Y)Total currentliabilities$18,704K (37.87%↑ Y/Y)Operating lease liability long term$55K Common stock, 0.001 parvalue per share ...$28K (-77.05%↓ Y/Y)Warrant liability$13,718K (34.31%↑ Y/Y)Accounts payable$2,234K (188.26%↑ Y/Y)Accrued liabilities$2,136K (-1.48%↓ Y/Y)Operating lease liability- current$616K (50.61%↑ Y/Y)

Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics, Inc. (UNCY)